IND-SWIFT Forges Partnership with ROCHE DIAGNOSTICS to expand TROP T Rapid assay in India

IND-SWIFT Forges Partnership with ROCHE DIAGNOSTICS to expand TROP T Rapid assay in India
Troponin-T is used to measure damage to the heart muscle and to differentiate between non- cardiac chest pains and heart attacks.
Roche Diagnostics India Pvt. Ltd. enters into an agreement with Ind-Swift Limited; a Chandigarh based pharmaceutical company to promote its test for detecting heart attack, TROP T rapid assay, in India. Roche Diagnostics India Pvt. Ltd. is part of Roche Group, a worldwide leader in the field of Medical Diagnostics and Pharmaceuticals. Roche Diagnostids' TROP T rapid assay is a point of care test which can detect whether a patient is having a heart attack through a simple whole blood test.

Troponin-T is used to measure damage to the heart muscle and to differentiate between non-cardiac chest pains and heart attacks. The TROP T rapid assay gives a reliable qualitative result within 15 minutes. Ind-Swift Ltd. has a Cardio Specific Field Force, CARDIASWIFT which has been marketing cardio & anti-diabetic products for the last 8-10 years. Over the years, CARDIASWIFT has established a sound presence in the minds of cardiac and diabetic specialists and consulting physicians. Ind-Swift Limited will promote TROP T to cardiologists / diabectologists / consulting physicians/general practitioners all over the country with its 225 Strong Field Force. This collaboration with Roche Diagnostics India Pvt. Ltd. will give ISL a big chance to develop a strong presence in the cardiac field with some of the most established and renowned specialists and hospitals", said an elated Dr. Gopal Munjal, M.D & C.E.0, Ind-Swift Group.

Speaking on the occasion, Dr. Bhuwnesh Agrawal, Chairman and Managing Director, Roche Diagnostics India and South Asia said, "With a strong commercial partner like Ind-Swift Limited we are confident to penetrate in our target markets and reach out to doctors and patients throughout India and therewith reduce the burden of cardiovascular mortality in our country". Reforms Espoused In Education System
Polytechnic education and industrial training commissioner Mrs. Usha R Sharma addressing a gathering during a panel discussion at PHD Chamber in Sec-31, Chandigarh, on Friday. A daylong discussion on the subject ‘Are Reforms required in the Education System in India’ organised by the Indo-Swift evoked thought-provoking and pragmatic deliberations. Stressing the need to give education a broader connotation than it being mere literacy, the speakers, most of them educationists, supported the idea of finishing school of education. Mrs. Usha R Sharma, commissioner, polytechnic education and industrial training, chaired the function. The other panelists included Dr. SS Gill, vice-chancellor, Baba Farid University of Health Sciences;Mr. DK Dhawan, professor of department of biophysics, Panjab University; and Videocon vice-president Mr. Prem Ojha. Mr.Vivek Atray, additional transport commissioner, Haryana, was the moderator for the event.
IND-SWIFT is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products. Three visionaries Jains, Mehtas and Munjals, dedicated themselves to work for humanity’s quest for longer, happier and healthier lives . IND-SWIFT has been ranked 35th among top Indian Pharmaceutical companies. IND-SWIFT is ISO 9001-2008, WHO GMP certified and is listed on Bombay Stock Exchange and National Stock Exchange . We ensure value for money by developing innovative, therapies and process to produce safe effective and consistent quality pharmaceutical products delivering across the globe. IND-SWIFT is a research driven forward looking pharmaceutical company having world class expertise in finished goods dosage and active pharmaceutical ingredients (API’s)and herbal products. IND-SWIFT is proud to be the second largest drug manufacturers of North India. IND-SWIFT’S multipurpose, multilocation manufacturing set-ups are spread across the lush-green plains of northern India. The facilities are built according to current guidelines of MHRA, EU, WHO, and accreditations with ISO 14000 series standards.With strong network presence in more than 45 countries we are committed to provide quality medicines and better health care. The company has dedicated research and development department well equipped with the latest equipments and supported by a large pool, of scientists who continuously work towards new pharma products. Apart from being among top indian pharma companies, IND-SWIFT has also progressively embarked in diversification into multifarious fields viz Infrastructure, Printing Packaging and Stationery, Education, and Media Publication with its every unit as an independent profit earning centre. Mrs. Usha advocated counseling of the students at an initial stage in schools itself, in terms of the career option they wanted to choose. "Proper education and career of choice would enhance students’ productivity," she added. Mr.Atray said the purpose of education is to ultimately prepare students to compete and grow in the professional world so it should involve real-world exposure and activities. Mr.Ojha said practical and feasible ways for better education are by arrainging frequent interactions with experts or role models from industry or other fields. Mr.Dhawan said foreign direct investments must be encouraged in educational institutes for exposure to fair competition and international faculty.

Dr. G Munjal, managing director and CEO, Ind-Swift, espoused the need for finishing schools where the students can be transformed into the best product in terms of individual personalities and contributing elements to society. He concluded the discussion by saying that stern rules and regulations and their strict implementation could usher in positive results in government and private educational institutes. The purpose of education is to ultimately prepare students to compete in professional world, so it should involve real-world exposure.